The MCL-1 inhibitor S63845 reduced viability of SCLC cell lines in vitro with an IC50 of 23 to 78 nM by inducing apoptosis, while in vivo treatment of two xenograft models reduced tumor volumes to a comparable degree as cisplatin in combination with etoposide [56]. Here, MCL1 is linked to neoplasm.